Báo cáo khoa học: Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane pot

Role of different moieties from the lipooligosaccharide
molecule in biological activities of the Moraxella
catarrhalis outer membrane
Daxin Peng
1,
*, Wei-Gang Hu
1,
†, Biswa P. Choudhury
2
, Artur Muszyn
´
ski
2
, Russell W. Carlson
2
and Xin-Xing Gu
1
1 Vaccine Research Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville,
MD, USA
2 Complex Carbohydrate Research Center, University of Georgia, Athens, GA, USA
Moraxella catarrhalis, once considered a nonpatho-
genic bacteria to humans, is now one of the leading
causes of bacterial otitis media in children, after Strep-
tococcus pneumoniae and Haemophilus influenzae [1–3].
In developed countries, more than 80% of children
under the age of 3 years will be diagnosed at least once
Keywords
lipooligosaccharide; moiety; Moraxella
catarrhalis; outer membrane; role
Correspondence
Xin-Xing Gu, 5 Research Court,

Room 2A31, Rockville,
MD 20850, USA
Fax: +1 301 435 4040
Tel: +1 301 402 2456
E-mail:
Present addresses
*School of Veterinary Medicine,
Yangzhou University, Yangzhou,
Jiangsu, China
†Defence Research and Development
Canada-Suffield, Medicine Hat, Alberta,
Canada
Database
The nucleotide sequence of lgt3 gene in
Moraxella catarrhalis strain O35E has been
submitted to the GenBank database under
the accession number DQ208195
(Received 19 June 2007, revised 30 July
2007, accepted 21 August 2007)
doi:10.1111/j.1742-4658.2007.06060.x
Lipooligosaccharide (LOS), a major component of the outer membrane of
Moraxella catarrhalis, consists of two major moieties: a lipid A and a core
oligosaccharide (OS). The core OS can be dissected into a linker and three
OS chains. To gain an insight into the biological activities of the LOS
molecules of M. catarrhalis, we used a random transposon mutagenesis
approach with an LOS specific monoclonal antibody to construct a sero-
type A O35E lgt3 LOS mutant. MALDI-TOF-MS of de-O-acylated LOS
from the mutant and glycosyl composition, linkage, and NMR analysis of
its OS indicated that the LOS contained a truncated core OS and consisted
of a Glc-Kdo

2
(linker)-lipid A structure. Phenotypic analysis revealed that
the mutant was similar to the wild-type strain in its growth rate, toxicity
and susceptibility to hydrophobic reagents. However, the mutant was sensi-
tive to bactericidal activity of normal human serum and had a reduced
adherence to human epithelial cells. These data, combined with our previ-
ous data obtained from mutants which contained only lipid A or lacked
LOS, suggest that the complete OS chain moiety of the LOS is important
for serum resistance and adherence to epithelial cells, whereas the linker
moiety is critical for maintenance of the outer membrane integrity and sta-
bility to preserve normal cell growth. Both the lipid A and linker moieties
contribute to the LOS toxicity.
Abbreviations
BHI, brain-heart infusion; CFU, colony forming units; COPD, chronic obstructive pulmonary disease; DPBSG, Dulbecco’s phosphate-buffered
saline containing 0.05% gelatin; EU, endotoxin units; Kdo, 3-deoxy-
D-manno-2-octulosonic acid; kds, 3-deoxy-D-manno-2-octulosonic acid
transferase; LOS, lipooligosaccharide; lpxA, UDP-N-acetylglucosamine acyltransferase; OMPs, outer membrane proteins; OMVs, outer
membrane vesicles; OS, oligosaccharide.
5350 FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works
with otitis media, and M. catarrhalis is responsible for
15–25% of those cases [4,5]. M. catarrhalis is also a
common cause of lower respiratory tract infections in
adults with chronic obstructive pulmonary disease
(COPD), the fourth leading cause of death in the Uni-
ted States [6,7]. Lower respiratory tract infections have
been shown to contribute to the progression of the
COPD. Approximately 20 million cases of such exacer-
bations are reported each year in the United States, up
to 35% of them resulting from M. catarrhalis infec-
tions.

The pathogenesis of M. catarrhalis infection is not
well understood. As a gram-negative bacterium,
M. catarrhalis without capsular polysaccharides is
surrounded by an outer membrane, consisting of lipo-
oligosaccharide (LOS), outer membrane proteins
(OMPs) and pili outside phospholipids [2]. The outer
membrane of gram-negative bacteria was initially con-
sidered to protect the bacteria from several antibiotics,
dyes, and detergents (hydrophobic compounds) which
would normally damage the cell wall. However, more
outer membrane biological activities have become
apparent over years of extensive research and there is
indication today that the outer membrane of gram-
negative bacteria has some other biological activities,
such as adherence and invasion in vitro, colonization
in vivo, maintenance of cell surface charge and serum
bactericidal resistance [8–13].
Which component on the outer membrane of
M. catarrhalis contributes to the above-mentioned bio-
logical activities? Several OMPs of M. catarrhalis were
identified, but their functions were mainly reported as
potential vaccine antigens, although some of them
were indicated to be adhesins [5,14–17]. Pili were con-
sidered to be associated with bacterial attachment, but
both piliated and nonpiliated M. catarrhalis strains
could adhere to human mucosal cells in vitro [18]. LOS
has mostly been investigated for these biological activi-
ties of the M. catarrhalis outer membrane [19–24].
M. catarrhalis LOS is a major component of the
bacterial outer membrane with three main serotypes A,

B and C, of which serotype A is the major type
[25,26]. Quite a few studies have demonstrated that
such an LOS molecule is an important virulence factor
for some other respiratory tract pathogens, such as
Neisseria meningitidis, Neisseria gonorrhoeae, and
H. influenza [27–29]. Studies have also implicated the
M. catarrhalis LOS as important in the pathogenesis
of the M. catarrhalis infection [13,21,23,24]. We
recently reported that a mutant which lacked LOS
showed decreased toxicity, reduced resistance to nor-
mal human serum killing, and reduced adherence to
human epithelial cells in vitro and in vivo, while show-
ing hypersensitivity to hydrophobic compounds, indi-
cating that LOS contributes to most biological
activities of the M. catarrhalis outer membrane [24].
The molecular structure of the M. catarrhalis LOS is
smaller than its lipopolysaccharide counterparts in
gram-negative pathogens like Escherichia coli and Sal-
monella typhimurium and does not have the O-anti-
genic side chain of the repeating units characteristic of
classical lipopolysaccharide. As showed in Fig. 1, the
LOS consists of lipid A and a core oligosaccharide
(OS). The latter can be further dissected into three OS
chains and a linker composed of a central Glc and two
3-deoxy-d-manno-2-octulosonic acids (Kdo). How do
the three moieties play their roles in biological activi-
ties of the outer membrane? Biosynthesis of LOSs in
M. catarrhalis is complex and strictly sequential,
requiring many enzymes such as UDP-glucose-4-epi-
merase, Kdo-8-phosphate synthase, Kdo transferase

(kdt), glycosyltransferase enzymes, and UDP-N-acetyl-
glucosamine acyltransferase (lpxA). Recently, several
genes encoding these enzymes have been reported
[20,22–24,26,30–32]. A series of stepwise-truncated
LOS mutants can therefore be established by knocking
out some of the genes and then the biological activities
of the different truncated LOS mutants can be
Fig. 1. Schematic structure of M. catarrhalis
LOS [8]. Lipooligosaccharide (LOS) consists
of two major moieties: lipid A and a core
oligosaccharide (OS). The core OS can
further be dissected into three OS chains
and a linker (boxed) composed of a Glc and
two Kdo. p, pyranose.
D. Peng et al. LOS role in M. catarrhalis outer membrane
FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works 5351
compared to decipher potential roles of each moiety of
the LOS. Previously, we identified an lpxA gene encod-
ing UDP-N-acetylglucosamine acyltransferase and a
kdtA gene encoding Kdo transferase [23,24]. The lpxA
or the kdtA mutant contained no LOS or lipid A-only
structure. Both mutants showed a variety of changes
of biological activities in vitro as well as in vivo. In this
study, we further found an lgt3 gene by a random
transposon mutagenesis approach followed with a
screen by an LOS-specific mAb. A subsequently iso-
genic lgt3 mutant contained a truncated core OS and
consisted of a linker (Glc-Kdo
2
)-lipid A structure. The

phenotype of this mutant was examined to investigate
the roles of different moieties of the LOS molecule in
biological activities of the M. catarrhalis outer mem-
brane.
Results
Construction of M. catarrhalis O35Elgt3 mutant
M. catarrhalis O35E mutants were constructed by
in vitro transposon mutagenesis. The resulting kanamy-
cin-resistant colonies were screened for loss of reactiv-
ity to a specific anti-LOS mAb 8E7. Two clones were
selected and the EZ:TN transposon was found to be
inserted at position 901 and 1203 of an open reading
frame (ORF) of 1605 bp, respectively (Fig. 2). BLAST
searches at GenBank with the deduced polypeptide
sequence of the ORF revealed 99.6% and 100% iden-
tity with a recently identified lgt3 gene encoding b(1–4)
glucosyltransferase of M. catarrhalis serotype B strain
7169 [30] and a putative lgt3 gene from a serotype A
strain 25238 [26], respectively.
An lgt3 knockout mutant of M. catarrhalis O35E
was constructed by allelic exchange with an insertion
of a kanamycin-resistant cassette and deletion of an
822 bp fragment between two HindIII sites of the lgt3
(Fig. 2).
Silver staining revealed that the mutant LOS mole-
cule migrated more rapidly and showed less density
than those of the wild-type, indicating a truncated
LOS molecule resulting from the mutant (Fig. 3A).
Western blot analysis demonstrated that the LOS from
O35Elgt3 lost the binding activity to the mAb 8E7

when compared with the wild-type strain (Fig. 3B).
Purified LOSs from both strains also showed similar
results to those described above (data not shown). To
further compare LOS expression levels between the
wild-type and mutant strains, the amounts of Kdo
from both strains were determined as an indicator.
They were 73 ng and 70 ng per 80 lg of outer mem-
brane vesicles (OMVs) for the wide type and mutant
strains, respectively, indicating the LOS expressions in
both strains were similar.
Composition analysis by GC-MS showed that the
carbohydrates derived from the wild-type O35E strain
consisted of Glc, Gal, GlcNAc and Kdo, whereas the
carbohydrates derived from the mutant O35Elgt3 con-
sisted exclusively of Glc and Kdo. The glycosyl linkage
analysis by GC-MS showed that the OSs from the
wild-type strain consisted of terminal-, 2-, 4-, and
3,4,6-linked glucosyl residues, terminal- and 4-linked
galactosyl residues, and a terminal-linked N-acetylglu-
cosaminosyl residue. These linkage results were consis-
tent with the structure of the LOS reported for
serotype A strain 25238 [33]. The only hexosyl residue
in the mutant LOS structure was terminally linked
Glc.
Fig. 2. Strategy for construction of the lgt3 mutant in M. catarrhalis
O35E. Large arrows represent the direction of transcription; the
site of the transposon insertion identified in the O35E is denoted
as EN:TN, and the location of the deletion replaced by the kanamy-
cin-resistant gene (kanR) is between two HindIII cleavage sites.
The sites of primers used are indicated as small arrows (25, 26,

and 40 of Table 1).
AB
Fig. 3. LOS patterns of SDS ⁄ PAGE followed by silver staining (A)
or western blotting (B) of M. catarrhalis wild-type strain O35E
(lane 1) and mutant O35Elgt3 (lane 2). Each lane represents
extracts from proteinase K-treated whole cell lysates from 1.9 lg
of each bacterial suspension. An anti-LOS MAb 8E7 was used at
1 : 100 dilution (B). Molecular markers (Mark 12; Invitrogen) are
indicated on the left.
LOS role in M. catarrhalis outer membrane D. Peng et al.
5352 FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works
The de-O-acylated LOSs from the wild-type O35E
and the mutant O35Elgt3 were further analyzed by
MALDI-TOF MS (Fig. 4). The mass spectral data of
de-O-acylated LOS from O35E was consistent with the
reported structure of serogroup A LOS. Among
the major ions m ⁄ z 2672.8(M-H)
–
corresponds to the
molecular mass of the de-O-Ac LOS containing five
Glc, two Gal, one GlcNAc, two Kdo and de-O-acyl-
ated lipid-A bearing two phosphate moieties. The de-
O-acylated lipid-A unit consists of two GlcNAc and
two 3-OH C12:0 groups. Among the other ions m ⁄ z of
2654.8, 2694.8 and 2717.4 indicates the presence of the
anhydro form and mono- and di-sodiated form of the
molecular ion 2672.8 (Fig. 4A). Among other charac-
teristic ions, 1558.2 and 1778.4 represent the mass of
intact OS with one and two Kdo residues, respectively.
The low molecular mass with m ⁄ z of 895.4 is from the

Y-type fragment ion from the de-O-acylated lipid-A
portion (as observed in the negative mode). The ions
with m ⁄ z of 917.4 and 877.4 (unmarked) are mono-
sodiated and anhydro forms of 895.4 ion, respectively.
The ion with m ⁄ z of 797.4 was from the anhydro frag-
ment ion of de-O-acylated lipid-A bearing only one
phosphate group (Fig. 4A).
The MALDI-TOF mass spectral data of de-O-acyl-
ated LOS for the mutant O35Elgt3 showed the pres-
ence of ions with m ⁄ z of 1479.6, 1497.6, 1519.6 and
1541.6, respectively. The ion at m ⁄ z 1497.6 (M-H)
–
corresponds to the deprotonated molecular mass, con-
taining one Glc, two Kdo, de-O-acylated lipid-A and
two phosphate moieties. The ions with m ⁄ z of 1519.6
and 1541.6 are mono- and di-sodiated forms of the
de-O-acylated LOS and the ion with m ⁄ z of 1479.6 is
the anhydrous form of the de-O-acylated LOS. The
ion 1277.6 is the de-protonated molecular ion from
de-O-acylated LOS containing only one Kdo residue
(Fig. 4B). The low molecular ions with m ⁄ z of 917.4
and 877.4 are from the mono-sodiated and anhydro
forms of the Y-type fragment ion 895.4 arising from
the de-O-acylated lipid-A.
Finally, proton NMR spectra of carbohydrates from
both wild and mutant strains showed that the spec-
trum for the O35E carbohydrates was identical to that
published from strain 25238 LOS (Fig. 5) [33]. The
mutant carbohydrate spectrum showed only one ano-
meric resonance, a result consistent with a single termi-

nal-linked glucosyl residue in the above GC-MS
analysis.
Taken together, the O35Elgt3 mutant contained only
a linker-lipid A (Glc-Kdo
2
-lipid A) structure without
OS chains (Fig. 1).
Morphology, growth rate, and OMV
⁄
OMP
profiles of M. catarrhalis O35Elgt3 mutant
There were no significant differences in morphology,
growth rate, or OMV ⁄ OMP profiles between the wild-
type and the lgt3 mutant (data not shown). The yields
of OMVs from both strains were similar (data not
shown).
Susceptibility of M. catarrhalis O35Elgt3 mutant
A broad range of hydrophobic agents and a hydrophilic
glycopeptide were used to determine the susceptibility of
the mutant O35Elgt3. O35Elgt3 showed similar resis-
tance or intermediate susceptibility to hydrophobic anti-
biotics, reagents [azithromycin (15 lg), deoxycholate
(100 mgÆmL
)1
), fusidic acid (10 mgÆmL
)1
), novobiocin
A
B
Fig. 4. MALDI-TOF MS spectrum (negative mode) of the de-O-acyl-

ated LOS from M. catarrhalis wild-type strain O35E (A) and the
mutant O35Elgt3 (B). This analysis was done in the negative mode,
and all ions represented as deprotonated [M-H]
–
ions. The source
of the ions was as indicated in the structure shown in the inset.
The m ⁄ z 917.4 and 797.4 are due to sodiated and dehydrated
forms, respectively, of the m ⁄ z 895.4 fragment ion.
D. Peng et al. LOS role in M. catarrhalis outer membrane
FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works 5353
(5 lg), polymycin B (300 international units), rifampin
(5 lg), Triton X-100 (5%, w ⁄ v), Tween 20 (5%, v ⁄ v)]
and a hydrophilic glycopeptide, vancomycin (5 lg), as
the wild-type strain (data not shown).
Biological activity of M. catarrhalis O35Elgt3
mutant
The mutant was tested for LOS-associated biological
activity. In a Limulus amebocyte lysate assay, whole
cell suspensions (D
620
¼ 0.1) gave 3.7 · 10
3
endotoxin
units (EU) mL
)1
for O35E and 2.0 · 10
3
EUÆmL
)1
for

the O35Elgt3 mutant. In a bactericidal assay with
normal human serum, strain O35E survived at 25%
normal human serum. However, 75% of the mutant
cells died at 25% normal human serum (P<0.05,
Fig. 6) indicating a reduced resistance from the
mutant.
To test the adherence of the O35Elgt3 mutant to
human epithelial cells, Chang and HeLa cell lines were
used. The adherence percentage of O35Elgt3 to Chang
and HeLa epithelia were 19.1 ± 4.6 and 27.3 ± 8.4,
respectively, whereas those of the wild-type were
41.7 ± 9.1 and 47.0 ± 4.1 (P<0.01).
To investigate the effect on survival of the O35Elgt3
mutant in a murine model of nasopharyngeal clear-
ance, mice were challenged with the wild-type or
mutant strains by aerosolization (Fig. 7). Mutant
A
B
Fig. 5. Proton NMR spectra of LOS derived from M. catarrhalis
O35E (A) and the mutant O35Elgt3 (B). For the O35E strain, the
assignments were made based on the identity of this spectrum
with that of the published structure for the LOS from type A
M. catarrhalis. The spectrum for the mutant lgt3 disaccharide
shows numerous resonances for the H3 protons of Kdo due to the
fact that a 5-linked Kdo residue can, on mild acid hydrolysis, form
4,8-anhydroKdo, 4,7-anhydroKdo, and 2,7-anhydroKdo; all of which
have different H3 resonances.
5.5
6
6.5

7
0 0.5 2.5 5 12.5 25 HI
Normal human Serum (%)
Bacterial counts (log CFU)
*
Fig. 6. Bactericidal activity of normal human serum against
M. catarrhalis wild-type strain O35E (black bar) and the mutant
O35Elgt3 (gray bar). ‘HI’ represents the group of 25% heat-
inactivated normal human serum. The data represent the average
of three independent assays. An asterisk represents statistical sig-
nificance between the wild-type and mutant strains.
0
1
2
3
4
5
0
Nasal wash
*
*
Time
p
ost challen
g
e (h)
Bacterial recovery
(log CFU/mouse)
3624
Fig. 7. Time courses of bacterial recovery in mouse nasal washes

after an aerosol challenge with M. catarrhalis wild-type strain O35E
(r) and the mutant O35Elgt3 (h). Each time point represents a
geometric mean of six mice. Asterisks represent statistical signifi-
cance between the wild-type and mutant strains.
LOS role in M. catarrhalis outer membrane D. Peng et al.
5354 FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works
O35Elgt3 present in the nasopharynx showed an accel-
erated clearance at 3 h (85.5% versus 60.2%,
P < 0.01) or 6 h (98.0% versus 86.8%, P < 0.01)
compared to the wild-type.
Discussion
In this study, an lgt3 gene was found and its products
confirmed from a M. catarrhalis serotype A strain
O35E through an isogenic O35Elgt3 mutant. Structural
analysis revealed that the O35Elgt3 mutant contained
a truncated core OS and consisted of a linker (Glc-
Kdo
2
)-lipid A structure, similar to that reported previ-
ously [30,34]. The O35Elgt3 mutant demonstrated no
significant difference in its growth rate, LOS expres-
sion level and susceptibility to the hydrophobic com-
pounds compared with the wild-type strain. However,
our previous mutants which lacked LOS [24] or con-
tained only lipid-A structure [23] showed reduced
growth rate and hypersusceptibility to the hydrophobic
compounds. It implies that the linker moiety of the
LOS might be critical for maintenance of outer mem-
brane integrity, stability or flexibility by resistance to
foreign hydrophobic compounds to preserve normal

cell growth. In addition, the O35Elgt3 mutant was sen-
sitive to the bactericidal activity of normal human
serum at 25% as compared with the wild-type strain,
but less sensitive than that of the mutant with lipid A-
only structure [23]. It indicates that the linker moiety
(Glc-Kdo
2
) might also contribute to the serum bacteri-
cidal resistance. However, another possibility also
exists. As the susceptibility of the lipid A-only mutant
to hydrophobic compounds was higher than that of
the O35Elgt3 mutant, the permeability barrier of the
outer membrane might significantly contribute to the
bactericidal activity of normal human serum, and
might cause a much more sensitive phenotype of the
lipid A-only mutant than that of the O35Elgt3 mutant.
Nevertheless, as the O35Elgt3 mutant did not change
its susceptibility to hydrophobic compounds but was
shown to be more sensitive to the bactericidal activity
of the human serum as compared with the wild-type
strain, it suggests that a complete OS chain moiety
contributes to the serum bactericidal resistance.
LOS toxicity was assumed to be associated only with
the lipid A moiety. By using Limulus amebocyte lysate
assay, we found that the O35E lgt3 mutant did not
show significant changes of the toxicity, whereas the
lipid A-only mutant [23] showed decreased toxicity
(6 · 10
2
EU Æ mL

)1
) six-fold as compared with the
wild-type strain (3.7 · 10
3
EU Æ mL
)1
), suggesting that
the LOS toxicity is attributable not only to the lipid A
moiety but also to the linker moiety (Glc-Kdo
2
).
Bacterial adherence to the surface of epithelial cells
plays a critical role in colonization and is believed to
be the first step in the pathogenesis of microbial infec-
tions. It has been reported that several LOSs from
respiratory tract bacteria are associated with bacterial
adherence [29,35,36]. Consistent with our previous
results from the lipid A-only mutant, the O35Elgt3
mutant showed more than a 50% reduction in attach-
ment to Chang or HeLa cells and enhanced clearance
from the mouse nasopharynx after an aerosol chal-
lenge when compared to the wild-type strain [23]. Our
data suggest that the M. catarrhalis adherence to epi-
thelial cells may not be associated with the linker and
lipid A moieties, but with the OS chain moiety.
In summary, we constructed a serotype A
M. catarrhalis O35Elgt3 mutant that produced a linker
(Glc-Kdo
2
)-lipid A structure. The mutant showed sig-

nificant changes in its biological activities in vitro and
in vivo. These data, combined with our previous data
from mutants which lacked LOS or contained only
lipid A structure, suggest that a complete OS chain
moiety of the M. catarrhalis LOS is important in bio-
logical activities such as serum resistance and adher-
ence of epithelial cells, the linker moiety is critical for
maintenance of outer membrane integrity and stability
to preserve normal cell growth, and both lipid A and
linker moieties contribute to the LOS toxicity.
Experimental procedures
Strains, plasmids, and growth conditions
Bacterial strains, plasmids and primers are given in Table 1.
M. catarrhalis strains were cultured on chocolate agar
plates (Remel, Lenexa, KS), or brain-heart infusion (BHI)
(Difco, Detroit, MI) agar plates at 37 °Cin5%CO
2
.
Mutant strains were selected on BHI agar supplemented
with kanamycin at 20 lgÆmL
)1
. Growth rates of wild-type
and mutant were measured as follows: an overnight culture
was inoculated in 10 mL of BHI media (adjusted D
600
¼
0.05) and shaken at 37 °C at 250 r.p.m. The bacterial
cultures were monitored spectrophotometrically at D
600
.

Escherichia coli was grown on Luria-Bertani agar plates or
broth with appropriate antibiotic supplementation. The
antibiotic concentrations used for E. coli were as follows:
kanamycin, 30 lgÆmL
)1
; and ampicillin, 50 lgÆmL
)1
.
General DNA methods
DNA restriction endonucleases, T4 DNA ligase, E. coli
DNA polymerase I Klenow fragment, and Taq DNA poly-
merase were purchased from Fermentas (Hanover, MD).
Preparation of plasmids, purification of PCR products and
D. Peng et al. LOS role in M. catarrhalis outer membrane
FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works 5355
DNA fragments were performed using kits manufactured
by Qiagen (Santa Clarita, CA). Bacterial chromosomal
DNA was isolated using a genomic DNA purification kit
(Promega, Madison, WI). DNA nucleotide sequences were
obtained via 3070xl DNA analyzer (Applied Biosystems,
Foster City, CA) and analyzed with dnastar software
(DNASTAR Inc., Madison, WI).
Transposon mutagenesis and identification
of lgt3 gene
In vitro transposon mutagenesis of M. catarrhalis was per-
formed as described previously [23]. The resulting kana-
mycin-resistant colonies were screened by colony blot
assay and further identified by whole cell enzyme-linked
immunosorbent assay (ELISA) for loss of binding reactiv-
ity to an anti-LOS MAb (8E7) generated by serotype A

strain O35E [21]. The transformants without the 8E7
binding activity were subsequently evaluated by examin-
ing the LOS profiles from proteinase-K-treated whole cell
lysates [37] on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS ⁄ PAGE) and LOS silver staining [38].
The clones with different LOS bands from the wild-type
LOS were selected for isolation of chromosomal DNA.
The DNA fragment with the transposon insertion was
subsequently sequenced and the lgt3 homologue from
strain O35E identified by BLAST searches at GenBank of
the National Center for Biotechnology Information,
Bethesda, MD.
Cloning of lgt3 homologue and construction
of the knockout mutants
The entire lgt3 was amplified from the chromosomal DNA
of M. catarrhalis strain O35E using primers 25 and 26
(Table 1, Fig. 2). The PCR product was cloned into
pCR2.1 using a TOPO TA cloning kit (Invitrogen, Carls-
bad, CA) to obtain pCRlgt3. The insert was released by
EcoRI-SalI digestion and then subcloned into an EcoRI-
SalI site of pBluescript SK(+) to form pSlgt3. The kana-
mycin-resistant gene from pUC4K was digested with EcoRI
and subsequently inserted into the lgt3 gene using the
HindIII site to form pSlgt3K.
After verification by sequence analysis, the mutagenic
lgt3 gene with the inserted kanamycin-resistant gene in
pSlgt3K was amplified by PCR and purified for electropo-
ration to O35E-competent cells. After 24 h incubation, the
resulting kanamycin-resistant colonies were selected for
PCR analysis of chromosomal DNA using primers 40 and

26 (Table 1, Fig. 2). An inactivated lgt3 mutant was verified
by sequence analysis and named as O35Elgt3.
LOS determination
A crude LOS extraction was performed from both the wild-
type strain O35E and the mutant O35Elgt3 using the
proteinase-K-treated whole cell lysate method [37]. The
resulting extracts from each bacterial suspension (1.9 lgof
protein amount) were resolved by 15% SDS ⁄ PAGE and
Table 1. Strains, plasmids, and primers used in this study.
Strains Description Source
E. coli TOP10 Cloning strain Invitrogen
M. catarrhalis O35E Wild-type strain (24)
M. catarrhalis O35E7 Strain with EZ::TN insertion in lgt3 gene (1203-bp) This study
M. catarrhalis O35E8 Strain with EZ::TN insertion in lgt3 gene (901-bp) This study
M. catarrhalis O35Elgt3 lgt3 knockout mutant strain of O35E This study
Plasmids
pCR2.1 TOPO TA cloning vector Invitrogen
pBluescript II SK(+) Cloning vector Fermentas
pUC4k Kanamycin-resistant gene Amersham
pCRlgt3 lgt3 cloned into pCR2.1 This study
pSlgt3 EcoRI-SalI lgt3 fragment cloned into SK(+) This study
pSlgt3K EcoRI-blunted kanamycin-resistant gene
inserted into blunted HindIII site of pSlgt3
with internal deletion
This study
Primers
25 5¢-CTC
GTC GAC ATG AAT ACA GCC AAG CGG-3¢ This study
lgt3 sense, SalI site underlined
26 5¢-CTC

GAA TTC TCA TGG TTT ATC CTT ATT-3¢ This study
lgt3 antisense, EcoRI site underlined
40 5¢-CAA CCC ATT TTC TAA GCT-3¢ This study
5¢ flanking DNA of lgt3 sense
LOS role in M. catarrhalis outer membrane D. Peng et al.
5356 FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works
visualized by silver staining [38]. Western blot using MAb
8E7 was performed [21].
To further quantify LOSs expressed on both the wild-
type and mutant strains, a Kdo assay was applied [39] with
OMVs prepared using an EDTA-heat induced method [40]
as whole cells were not applicable for the Kdo assay. The
amount of Kdo was determined by using 80 lg of OMVs
as samples and Kdo ammonium salt (Sigma, St. Louis,
MO) as a standard.
Structural analysis of LOS
For the composition analysis, 30–35 g of wet cells from
O35E and O35Elgt3 were prepared for LOS purification by
phenol–water extraction [41]. The purified LOSs were
washed with a 9 : 1 ethanol ⁄ water (v ⁄ v) mixture to remove
phospholipids. The OSs were prepared by mild acid hydro-
lysis of LOSs in 1% aqueous acetic acid (v ⁄ v) for 2.5 h at
100 °C and gel-filtration chromatography using Bio-Gel P-2
with deionized water as the eluent. The glycosyl composi-
tions of OSs in O35E and O35Elgt3 were determined by the
preparation and GC-MS analysis of trimethylsilyl methyl-
glycosides. The glycosyl linkages were determined by the
preparation and GC-MS analysis of partially methylated
aldiol acetates. Analysis of GC-MS was performed on an
HP)5890 GC interfaced to a mass selective detector

5970 MSD using a Supelco DB1 fused silica capillary col-
umn (30 m · 0.25 mm Internal diameter, J & W Scientific,
Folsom, California). For MS analysis, the LOS was
O-deacylated by treatment with anhydrous hydrazine for
20 min at 37 °C [42]. The de-O-acylated LOS samples were
dissolved in deionized water at 1 l g ÆlL
)1
concentration and
mixed with equal volumes of 0.5 m 2,5-dihydroxy benzoic
acid (matrix) in methanol and spotted with 1 lL on a 100-
well stainless steel MALDI plate. The mass spectra were col-
lected on a MALDI-TOF instrument (Applied Biosystems)
in the negative reflectron mode. NMR was performed on
the OSs by lyophilizing each sample from D
2
O (99.999 atom
percentage D, Sigma) twice, dissolved in D
2
O (100 atom
percentage D), and acquiring spectra using a Varian Ino-
va 500 or 600 MHz spectrometer (Varian, Palo Alto, CA).
Limulus amebocyte lysate assay
The chromogenic Limulus amebocyte lysate assay for
endotoxin activity was performed using the QCL-1000 kit
(Bio-Whittaker Inc., Walkersville, MD). Overnight cultures
from chocolate agar plates were suspended in BHI broth to
D
620
of 0.1 and serial dilutions of these stocks were tested.
Susceptibility determination

The sensitivity of strains to a panel of hydrophobic agents
or a hydrophilic glycopeptide was performed using
standard disk-diffusion assays [43]. Bacteria were cultured
in BHI to a D
600
of 0.2 and 100 lL portions of the bacte-
rial suspension were spread onto chocolate agar plates.
Antibiotic disks or sterile blank paper disks (6 mm, Becton
Dickinson, Cockeysville, MD) saturated with the various
agents were plated on the lawn in triplicate at 37 °C for
18 h. Sensitivity was assessed by measuring the diameter of
the zone of growth inhibition in two axes and the mean
value was calculated.
Bactericidal assay to normal human serum
A complement-sufficient normal human serum was pre-
pared and pooled from eight healthy adult donors. A bacte-
ricidal assay was performed in a 96-well plate [23]. Normal
human serum was diluted to 0.5, 2.5, 5.0, 12.5, and 25% in
pH 7.4 Dulbecco’s phosphate-buffered saline (NaCl ⁄ P
i
)
containing 0.05% gelatin (DPBSG). Bacteria (10 lLof10
6
colony forming units, CFU) were inoculated into 190 lL
reaction wells containing the diluted normal human serum,
25% of heat-inactivated normal human serum, or DPBSG
alone and incubated at 37 °C for 30 min. Serial dilutions
(1 : 10) of each well were plated onto chocolate agar plates.
The resulting colonies were counted after 24 h of incuba-
tion.

Adherence assay
Chang (conjunctival; CCL20.2) and HeLa (cervix; CCL-2)
human epithelial lines were cultured in Eagle’s minimal
essential medium (ATCC, Manassas, VA) supplemented
with 10% heat-inactivated fetal bovine serum in an atmo-
sphere of 5% CO
2
at 37 °C. A quantitative adherence assay
was performed on a 24-well tissue culture plate (Corning
Incorporated, Corning, NY) [34]. Adherence was expressed
as the percentage of bacteria attached to the human cells
relative to the original bacteria added to the well. The data
represent the average of three independent assays.
Nasopharyngeal clearance pattern in animal
model
Female BALB ⁄ c mice (6–8 weeks of age) were obtained
from Taconic Farms Inc. (Germantown, NY). The mice
were housed in an animal facility in accordance with
National Institutes of Health guidelines under animal study
protocol 1158–04. Bacterial aerosol challenges were carried
out in mice using the same D
540
value for wild-type strain
O35E (1.24 · 10
9
CFUÆmL
)1
) or mutant O35Elgt3
(8.2 · 10
8

CFUÆmL
)1
) in a 10 mL DPBSG [44]. The num-
bers of bacteria present in nasal washes were measured at
various time points postchallenge. The minimum detectable
number of viable bacteria was 4 CFU per nasal washing.
Clearance of M. catarrhalis was expressed as the percentage
D. Peng et al. LOS role in M. catarrhalis outer membrane
FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works 5357
of bacterial CFU at each time point compared with the
number deposited at time zero.
Statistical analysis
The adherence and clearance percentages were analyzed by
a Chi-square test.
Acknowledgements
We thank Eric J. Hansen for providing strain O35E,
Wenzhou Hong for assisting in the animal challenge,
and Robert Morell and Yandan Yang for helping in
DNA sequencing. This research was supported by the
Intramural Research Program of the NIH, NIDCD.
The analytical work was supported in part by the
Department of Energy-funded (DE-FG09–93ER20097)
Center for Plant and Microbial Complex Carbohy-
drates.
References
1 Catlin BW (1990) Branhamella catarrhalis: an organism
gaining respect as a pathogen. Clin Microbiol Rev 3,
293–320.
2 Murphy TF (1996) Branhamella catarrhalis: epidemiol-
ogy, surface antigenic structure, and immune response.

Microbiol Rev 60, 267–279.
3 Karalus R & Campagnari A (2000) Moraxella catarrh-
alis: a review of an important human mucosal pathogen.
Microbes Infect 2, 547–559.
4 Ruuskanen O & Heikkinen T (1994) Otitis media: etiol-
ogy and diagnosis. Pediatr Infect Dis J 13, S23–S26; dis-
cussion S50–S54.
5 Faden H, Hong J & Murphy T (1992) Immune
response to outer membrane antigens of Moraxella
catarrhalis in children with otitis media. Infect Immun
60, 3824–3829.
6 Verduin CM, Hol C, Fleer A, van Dijk H & van
Belkum A (2002) Moraxella catarrhalis: from
emerging to established pathogen. Clin Microbiol Rev
15, 125–144.
7 Murphy TF, Brauer AL, Grant BJ & Sethi S (2005)
Moraxella catarrhalis in chronic obstructive pulmonary
disease: burden of disease and immune response.
Am J Respir Crit Care Med 172, 195–199.
8 Holme T, Rahman M, Jansson PE & Widmalm G
(1999) The lipopolysaccharide of Moraxella catarrhalis
structural relationships and antigenic properties.
Eur J Biochem 265, 524–529.
9 Weiser JN & Gotschlich EC (1991) Outer membrane
protein A (OmpA) contributes to serum resistance and
pathogenicity of Escherichia coli K-1. Infect Immun 59,
2252–2258.
10 Hill SA (2000) Opa expression correlates with elevated
transformation rates in Neisseria gonorrhoeae. J Bacte-
riol 182, 171–178.

11 de O Ferreira E, Araujo Lobo L, Barreiros Petropolis
D, Dos S Avelar KE, Ferreira MC, e Silva Filho FC,
Domingues RM (2006) A Bacteroides fragilis surface
glycoprotein mediates the interaction between the bacte-
rium and the extracellular matrix component laminin-1.
Res Microbiol 157, 960–966.
12 Shin S, Lu G, Cai M & Kim KS (2005) Escherichia coli
outer membrane protein A adheres to human brain
microvascular endothelial cells. Biochem Biophys Res
Commun 330 , 1199–1204.
13 Attia AS, Lafontaine ER, Latimer JL, Aebi C, Syro-
giannopoulos GA & Hansen EJ (2005) The UspA2 pro-
tein of Moraxella catarrhalis is directly involved in the
expression of serum resistance. Infect Immun 73, 2400–
2410.
14 Easton DM, Smith A, Gallego SG, Foxwell AR, Cripps
AW & Kyd JM (2005) Characterization of a novel
porin protein from Moraxella catarrhalis and identifica-
tion of an immunodominant surface loop. J Bacteriol
187, 6528–6535.
15 McMichael JC (2000) Vaccines for Moraxella catarrhal-
is. Vaccine 19 (Suppl. 1), S101–S107.
16 Murphy TF, Kirkham C, Liu DF & Sethi S (2003)
Human immune response to outer membrane protein
CD of Moraxella catarrhalis in adults with chronic
obstructive pulmonary disease. Infect Immun 71, 1288–
1294.
17 Pearson MM, Laurence CA, Guinn SE & Hansen EJ
(2006) Biofilm formation by Moraxella catarrhalis
in vitro: roles of the UspA1 adhesin and the Hag

hemagglutinin. Infect Immun 74, 1588–1596.
18 Ahmed K, Matsumoto K, Rikitomi N & Nagatake T
(1996) Attachment of Moraxella catarrhalis to pharyn-
geal epithelial cells is mediated by a glycosphingolipid
receptor. FEMS Microbiol Lett 135, 305–309.
19 Akgul G, Erturk A, Turkoz M, Turan T, Ichinose A,
Nagatake T & Ahmed K (2005) Role of lipooligosac-
charide in the attachment of Moraxella catarrhalis to
human pharyngeal epithelial cells. Microbiol Immunol
49, 931–935.
20 Zaleski A, Scheffler NK, Densen P, Lee FK, Campag-
nari AA, Gibson BW & Apicella MA (2000) Lipooligo-
saccharide P (k) (Galalpha1–4Galbeta1–4Glc) epitope of
Moraxella catarrhalis is a factor in resistance to bacteri-
cidal activity mediated by normal human serum. Infect
Immun 68 , 5261–5268.
21 Hu WG, Chen J, McMichael JC & Gu XX (2001)
Functional characteristics of a protective monoclonal
antibody against serotype A and C lipooligosaccharides
from Moraxella catarrhalis. Infect Immun 69, 1358–
1363.
LOS role in M. catarrhalis outer membrane D. Peng et al.
5358 FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works
22 Luke NR, Allen S, Gibson BW & Campagnari AA
(2003) Identification of a 3-deoxy-D-manno-octulosonic
acid biosynthetic operon in Moraxella catarrhalis and
analysis of a KdsA-deficient isogenic mutant. Infect
Immun 71, 6426–6434.
23 Peng D, Choudhury BP, Petralia RS, Carlson RW &
Gu XX (2005) Roles of 3-deoxy-D-manno-2-octulosonic

acid transferase from Moraxella catarrhalis in lipooligo-
saccharide biosynthesis and virulence. Infect Immun 73,
4222–4230.
24 Peng D, Hong W, Choudhury BP, Carlson RW & Gu
XX (2005) Moraxella catarrhalis bacterium without
endotoxin, a potential vaccine candidate. Infect Immun
73, 7569–7577.
25 Vaneechoutte M, Verschraegen G, Claeys G & Van
Den Abeele AM (1990) Serological typing of Branham-
ella catarrhalis strains on the basis of lipopolysaccharide
antigens. J Clin Microbiol 28, 182–187.
26 Edwards KJ, Schwingel JM, Datta AK & Campagnari
AA (2005) Multiplex PCR assay that identifies the
major lipooligosaccharide serotype expressed by Morax-
ella catarrhalis clinical isolates. J Clin Microbiol 43,
6139–6143.
27 Song W, Ma L, Chen R & Stein DC (2000) Role of
lipooligosaccharide in Opa-independent invasion of
Neisseria gonorrhoeae into human epithelial cells. J Exp
Med 191, 949–960.
28 Gorter AD, Oostrik J, van der Ley P, Hiemstra PS,
Dankert J & van Alphen L (2003) Involvement of
lipooligosaccharides of Haemophilus influenzae and
Neisseria meningitidis in defensin-enhanced bacterial
adherence to epithelial cells. Microb Pathog 34, 121–
130.
29 Swords WE, Chance DL, Cohn LA, Shao J, Apicella
MA & Smith AL (2002) Acylation of the lipooligosac-
charide of Haemophilus influenzae and colonization: an
htrB mutation diminishes the colonization of human

airway epithelial cells. Infect Immun 70, 4661–4668.
30 Edwards KJ, Allen S, Gibson BW & Campagnari AA
(2005) Characterization of a cluster of three glycosyl-
transferase enzymes essential for Moraxella catarrhalis
lipooligosaccharide assembly. J Bacteriol 187, 2939–
2947.
31 Peak IR, Grice ID, Faglin I, Klipic Z, Collins PM, van
Schendel L, Hitchen PG, Morris HR, Dell A & Wilson
JC (2007) Towards understanding the functional role of
the glycosyltransferases involved in the biosynthesis of
Moraxella catarrhalis lipooligosaccharide. FEBS J 274,
2024–2037.
32 Wilson JC, Collins PM, Klipic Z, Grice ID & Peak IR
(2006) Identification of a novel glycosyltransferase
involved in LOS biosynthesis of Moraxella catarrhalis.
Carbohydr Res 341, 2600–2606.
33 Edebrink P, Jansson PE, Rahman MM, Widmalm G,
Holme T, Rahman M & Weintraub A (1994) Structural
studies of the O-polysaccharide from the lipopolysac-
charide of Moraxella (Branhamella) catarrhalis serotype
A (strain ATCC 25238). Carbohydr Res 257, 269–284.
34 Aebi C, Lafontaine ER, Cope LD, Latimer JL, Lumb-
ley SL, McCracken GH Jr & Hansen EJ (1998) Pheno-
typic effect of isogenic uspA1 and uspA2 mutations on
Moraxella catarrhalis 035E. Infect Immun 66, 3113–
3119.
35 Albiger B, Johansson L & Jonsson AB (2003) Lipooli-
gosaccharide-deficient Neisseria meningitidis shows
altered pilus-associated characteristics. Infect Immun 71,
155–162.

36 Swords WE, Buscher BA, Ver Steeg Ii K, Preston A,
Nichols WA, Weiser JN, Gibson BW & Apicella MA
(2000) Non-typeable Haemophilus influenzae adhere to
and invade human bronchial epithelial cells via an inter-
action of lipooligosaccharide with the PAF receptor.
Mol Microbiol 37, 13–27.
37 Tzeng YL, Datta A, Kolli VK, Carlson RW & Stephens
DS (2002) Endotoxin of Neisseria meningitidis com-
posed only of intact lipid A: inactivation of the menin-
gococcal 3-deoxy-D-manno-octulosonic acid transferase
J Bacteriol 184, 2379–2388.
38 Tsai CM & Frasch CE (1982) A sensitive silver stain for
detecting lipopolysaccharides in polyacrylamide gels.
Anal Biochem 119, 115–119.
39 Weissbach A & Hurwitz J (1959) The formation of
2-keto-3-deoxyheptonic acid in extracts of Escherichia
coli B. I. Identification. J Biol Chem 234
, 705–709.
40 Murphy TF & Loeb MR (1989) Isolation of the outer
membrane of Branhamella catarrhalis. Microb Pathog 6,
159–174.
41 Gu XX, Chen J, Barenkamp SJ, Robbins JB, Tsai CM,
Lim DJ & Battey J (1998) Synthesis and characteriza-
tion of lipooligosaccharide-based conjugates as vaccine
candidates for Moraxella (Branhamella) catarrhalis.
Infect Immun 66, 1891–1897.
42 Helander IM, Lindner B, Brade H, Altmann K, Lind-
berg AA, Rietschel ET & Zahringer U (1988) Chemical
structure of the lipopolysaccharide of Haemophilus
influenzae strain I-69 Rd- ⁄ b+. Description of a novel

deep-rough chemotype. Eur J Biochem 177, 483–492.
43 Ochsner UA, Vasil AI, Johnson Z & Vasil ML (1999)
Pseudomonas aeruginosa fur overlaps with a gene
encoding a novel outer membrane lipoprotein, OmlA.
J Bacteriol 181, 1099–1109.
44 Hu WG, Chen J, Battey JF & Gu XX (2000) Enhance-
ment of clearance of bacteria from murine lungs by
immunization with detoxified lipooligosaccharide from
Moraxella catarrhalis conjugated to proteins. Infect
Immun 68, 4980–4985.
D. Peng et al. LOS role in M. catarrhalis outer membrane
FEBS Journal 274 (2007) 5350–5359 Journal compilation ª 2007 FEBS. No claim to original US government works 5359